Key Account Manager, Cardiovascular (Munich, Germany)
Stellenbeschreibung
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
Our passion is anchored in our four core values:
- Patients are our North Star: Our actions and decisions are dedicated to benefiting patients and their caregivers.
- Science is in our Soul: We are committed to scientific excellence, integrity, and critical thinking, free from external influences.
- We > Me: Our strength lies in our unity and diversity.
- Make it Happen: We navigate challenges with tenacity, resilience, and a forward-thinking mindset, always holding ourselves accountable for delivering impactful results.
As a Key Account Manager (KAM), in Munich area, you will play a critical role in establishing Cytokinetics’ commercial presence in Germany and launching its first product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM). You will be accountable for developing relationships with leading hospitals, cardiology centers, and specialty networks across your territory.
The KAM will act as a trusted partner to healthcare professionals (HCPs), institutions while working cross-functionally with medical, market access, and marketing colleagues. Success in this role requires a strong combination of strategic account management, clinical acumen, and entrepreneurial drive to ensure that patients with HCM have timely access to innovative therapies.
Responsibilities
- Deliver sales results, work autonomously, and serve as single point of accountability for the successful launch within your territory
- Develop territory-specific account plans that identify, assess, and prioritize opportunities to meet customer needs by coordinating the efforts of a local integrated field team consisting of medical, payer, and patient navigation/support colleagues
- Be a subject matter expert and resource to customers through the delivery of clinically relevant disease and product information while focusing on creating demand for the product launch
- Communicate approved resources to HCPs for the benefit of HCM patients such as publications, marketing materials, payer information, patient support materials, and educational programs
Qualifications
- Min Bachelor's Degree or higher
- Eligibility to work as Pharmaceutical sales person according to §75 AMG
- Min 5+ years of experience in biotech/pharma sales required
- Experience as a commercial sales representative or key account manager with sole ownership of the territory is mandatory. Native German, and business fluent English is preferred.
- Cardiology, rare disease, or specialty product experience is preferred
- Product launch experience is a plus
- Knowledge of KOLs and key accounts within assigned territory is an advantage
- Expertise in evaluation of territory market trends and strategic planning that drives results and exceeds sales objectives is required
- Experience in selling to complex accounts, like university clinics, identifying influential stakeholders, and meeting specialty care HCP needs in hospital as well as office-based setting, is required
- Scientific acumen with a passion for understanding and championing the needs of customers and their patients, is important
- Willingness to travel overnight occasionally, depending on business needs and geography, is required
- Valid driver’s license to operate a company vehicle
Pay Range:
Pay RangeThe salary range for this role is €90,000-€120,000 gross annually. Final compensation will depend on skills, experience, and internal equity considerations.
In line with Germany equal pay regulations, we apply objective, gender-neutral criteria to determine compensation. We actively monitor pay equity through our annual Gender Equality Index and are committed to maintaining fair and transparent pay practices.
In compliance with Germany pay transparency legislation, compensation for this role is based on objective criteria and is aligned with our company-wide salary register. We are committed to ensuring equal pay for work of equal value.
Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.
Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.
Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.
Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers
Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.
Here are some ways to check for authenticity:
- We do not conduct job interviews through non-standard text messaging applications
- We will never request personal information such as banking details until after an official offer has been accepted and verified
- We will never request that you purchase equipment or other items when interviewing or hiring
- If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at [email protected]
Please visit our website at:
Cytokinetics is an Equal Opportunity Employer
Genannte Fähigkeiten

Cytokinetics was born from a vision shared by four pioneering scientists from Stanford, UCSD, and UCSF: James Spudich, Ronald Vale, James Sabry, and Lawrence S.B. Goldstein. In 1997, they laid the groundwork for a company that would delve into the intricate world of cytoskeletal proteins, seeking novel pharmacological targets. Operations officially commenced in 1998, initially with a broad focus on the potential applications of drugs based on these proteins. Robert I. Blum joined the nascent venture in 1998, playing a crucial role in business development, corporate development, and R&D, helping to operationalize the founders' scientific vision. As the company evolved, its scientific curiosity sharpened, eventually narrowing its focus to the complex mechanics of muscle biology. This strategic pivot marked a defining moment, setting Cytokinetics on a path to become a leader in understanding and targeting muscle function and contractility. The early 2000s were a period of growth and establishment, culminating in the company's initial public offering (IPO) in 2004, a significant milestone that fueled its research and development endeavors. In January 2007, Robert I. Blum, who had been integral to the company since its early days, was appointed President and CEO, a role he continues to hold. Under his leadership, Cytokinetics has forged critical collaborations, such as the 2013 licensing and discovery deal with Astellas to research treatments for muscle weakness and fatigue, and a 2020 financing deal with Ji Xing Pharmaceuticals to commercialize aficamten in China. For over two decades, Cytokinetics has remained dedicated to pioneering innovation in muscle biology, striving to develop first-in-class muscle activators and next-in-class muscle inhibitors. Their mission is to address debilitating diseases where muscle performance is compromised, aiming to improve the healthspan and lives of patients suffering from cardiovascular and neuromuscular conditions.
Auf diese Stelle bewerben
Use the application link supplied with this listing to apply to cytokinetics. Check the destination before entering personal information.
